August 2022

Specialty pharmacists play critical role in supporting treatment adherence.

Disease management is moving toward holistic care of the patient in the long term.

The disease can often be detected and managed early before a patient experiences signs or symptoms.

Gene therapies in late-stage development may soon provide hope for a cure.

Precise, more potent therapy can offer reduced toxicity.

Building a team to support best practices, medication safety, and staff education can reduce risks.

New drugs, virtual care, and a patient-focused approach are key during this period of transformation.

Oncology pharmacists must think critically about the digital experience they give patients.

Professionals address key challenges including structural racism and the hematology-oncology pharmacist great migration.

As local drug delivery technology evolves, the field is set for monumental change.

Specialty pharmacies are well positioned to address disparities that affect outcomes.

Increasingly, practices will use and evaluate ePROs and DSMSTs in cancer care settings.

Health care systems have made great strides by examining the diversity and equity of staffing.